- Amplify Treatments, Testing and Advancements ETF (USD) (US0321085815)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

全选清除所有

保存关闭

(%)

US0321085815

ISIN

交易所交易基金 (ETF)

基金类型

Amplify Investments

提供商

19,34 USD

每股资产净值 | 2024-09-05

2020-06-17

成立日期

4 每年的次数

股息的支付

CEOJMS

CFI

代码

Closed

Status

Equity

投资项目

Healthcare

部门

USA

地区分布

Prime Treatments, Testing and Advancements Index

基准

0.68 %

总成本比率

9,67 百万 USD

基金资产总量 | 2024-09-05

9,67 百万 USD

股票类资产 | 2024-09-05

否

UCITS

价格动态的变化

Fund profile

The Amplify Treatments, Testing and Advancements ETF seeks to replicate as closely as possible the price and yield performance of the Prime Treatments, Testing and Advancements Index by investing in a portfolio comprised primarily of U.S. companies engaged in and at the forefront of R&D, vaccines, therapies and testing technologies

profile

The Amplify Treatments, Testing and Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The Amplify Investments fund’s base currency is USD and the share class was registered 17.06.2020 with unique ISIN - US0321085815. The total expense ratio is 0.68%. The Amplify Treatments, Testing and Advancements ETF (USD) pays dividends 4 time(s) per year.

- Amplify Treatments, Testing and Advancements ETF (USD) (US0321085815)

价格动态的变化

Fund profile

profile

收入支付 (US0321085815)

其他 ETF 和基金提供商

相关 ETF 和基金